These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24451005)

  • 1. "About Brugada phenocopy": Brugada phenocopy with a flecainide overdose: a pharmacological dose effect?
    Chubb H; Cooklin M; Rosenthal E
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):E1. PubMed ID: 24451005
    [No Abstract]   [Full Text] [Related]  

  • 2. About Brugada phenocopy: Brugada phenocopy with a flecainide overdose: a pharmacological dose effect?
    Anselm DD; Baranchuk A
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):E2. PubMed ID: 24451029
    [No Abstract]   [Full Text] [Related]  

  • 3. Brugada phenocopy with a flecainide overdose: a pharmacological dose effect?
    Chubb H; Cooklin M; Rosenthal E
    J Cardiovasc Electrophysiol; 2014 May; 25(5):547-548. PubMed ID: 24303843
    [No Abstract]   [Full Text] [Related]  

  • 4. Wide Complex Tachycardia in a Patient With a History of Atrial Fibrillation.
    Hegde S; Kumar V
    JAMA Intern Med; 2016 Mar; 176(3):386-8. PubMed ID: 26784121
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term flecainide therapy in type 3 long QT syndrome.
    Chorin E; Taub R; Medina A; Flint N; Viskin S; Benhorin J
    Europace; 2018 Feb; 20(2):370-376. PubMed ID: 28339995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ECG diagnosis: flecainide toxicity.
    Levis JT
    Perm J; 2012; 16(4):53. PubMed ID: 23251119
    [No Abstract]   [Full Text] [Related]  

  • 7. Permanent atrioventricular block after flecainide testing.
    Luna-López R; Datino T; Espinosa MÁ; Fernández-Avilés F; Arenal Á
    Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):177-178. PubMed ID: 31631050
    [No Abstract]   [Full Text] [Related]  

  • 8. Does a Brugada pattern ECG precipitated by excessive-dose flecainide provide a diagnosis of a Brugada syndrome patient and/or contraindicate its use? A case study.
    Reiffel JA
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):e47-51. PubMed ID: 21846883
    [No Abstract]   [Full Text] [Related]  

  • 9. Brugada-type ECG pattern in patients treated with oral flecainide for lone atrial fibrillation: is there any clinical implication?
    Letsas KP; Weber R; Arentz T; Kalusche D
    Hellenic J Cardiol; 2009; 50(4):338-9. PubMed ID: 19622506
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced Brugada syndrome.
    Yap YG; Behr ER; Camm AJ
    Europace; 2009 Aug; 11(8):989-94. PubMed ID: 19482855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is flecainide dangerous in long QT-3 patients?
    Beinart R; Michailidis A; Gurevitz OT; Glikson M
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):143-5. PubMed ID: 19140927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of flecainide induced negative inotropy: An in silico study.
    Yang PC; Giles WR; Belardinelli L; Clancy CE
    J Mol Cell Cardiol; 2021 Sep; 158():26-37. PubMed ID: 34004185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.
    Padfield GJ; AlAhmari L; Lieve KV; AlAhmari T; Roston TM; Wilde AA; Krahn AD; Sanatani S
    Heart Rhythm; 2016 Feb; 13(2):609-13. PubMed ID: 26416620
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flecainide-induced prolongation of ventricular repolarization contributes to the proarrhythmic profile of action.
    Osadchii OE
    Int J Cardiol; 2015 Oct; 197():81-2. PubMed ID: 26142191
    [No Abstract]   [Full Text] [Related]  

  • 16. Flecainide overdose causing a Brugada-type pattern on electrocardiogram in a previously well patient.
    Soni S; Gandhi S
    Am J Emerg Med; 2009 Mar; 27(3):375.e1-375.e3. PubMed ID: 19328402
    [No Abstract]   [Full Text] [Related]  

  • 17. Brugada pattern masquerading as ST-segment elevation myocardial infarction in flecainide toxicity.
    Chhabra L; Spodick DH
    Indian Heart J; 2012; 64(4):404-7. PubMed ID: 22929826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are all sodium channel blockers created equal? Clinical-basic correlations based on observations in Brugada syndrome.
    Nattel S
    Heart Rhythm; 2005 Mar; 2(3):261-2. PubMed ID: 15851315
    [No Abstract]   [Full Text] [Related]  

  • 19. [Brugada electrocardiographic pattern elicited by flecainide overdose].
    Martínez-Mateo V; Arias MA; Rodríguez-Padial L
    Med Clin (Barc); 2011 Mar; 136(7):320. PubMed ID: 20452627
    [No Abstract]   [Full Text] [Related]  

  • 20. Probing flecainide block of I
    Geng L; Kong CW; Wong AOT; Shum AM; Chow MZY; Che H; Zhang C; Yau KL; Chan CW; Keung W; Li RA
    Toxicol Lett; 2018 Sep; 294():61-72. PubMed ID: 29758359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.